Mounjaro Dosing Schedule: Complete Titration Guide from 2.5 mg to 15 mg

Mounjaro uses a gradual dose escalation over 20 or more weeks to reduce side effects and find the right maintenance dose. Here is the full schedule, what to expect at each level, and how to handle common dosing questions.

One of the most common questions people have when starting Mounjaro is about the dosing schedule. Unlike medications that start at a fixed dose, tirzepatide uses a deliberate step-up approach. You begin at 2.5 mg and gradually increase, with your prescriber deciding when and whether to move to higher doses. Understanding why this process exists and what to expect at each step can make the experience considerably less stressful.

The FDA-Approved Titration Schedule

The prescribing information approved by the FDA specifies five dose levels. Each dose is administered once weekly by subcutaneous injection.

At minimum, you will spend 4 weeks on 2.5 mg before moving to 5 mg. After that, each subsequent increase should also follow a minimum of 4 weeks at the current dose. The fastest possible titration from 2.5 mg to 15 mg takes 20 weeks, though many prescribers extend this timeline based on tolerability.

Why Start at 2.5 mg?

The 2.5 mg dose is explicitly described in the FDA label as a starting dose, not a therapeutic dose. It does not produce meaningful A1C reduction or weight loss in most patients. Its purpose is entirely practical: to let the gastrointestinal tract adapt to the medication.

Tirzepatide slows gastric emptying, which is part of how it works. But introducing this effect abruptly can cause significant nausea, vomiting, and diarrhea. The 2.5 mg starting dose gives the body a chance to adjust before reaching doses that have real pharmacological impact.

In the SURPASS-1 trial, even with this gradual start, about 12 to 18 percent of patients reported nausea during the early weeks. Without the initiation period, rates would likely be higher.

What to Expect at Each Dose Level

2.5 mg (Weeks 1-4)

Most patients tolerate this dose well. Some experience mild nausea, particularly in the first one or two weeks. You may notice slightly reduced appetite, but substantial changes in blood sugar or weight are unlikely. Think of this as the acclimation period.

This is a good time to establish your injection routine: pick a consistent day, learn the pen mechanism, and decide on your injection site rotation (abdomen, thigh, or upper arm).

5 mg (Weeks 5-8)

This is where the medication begins to work. In the SURPASS trials, the 5 mg dose reduced A1C by an average of 1.87 percent and body weight by about 7.0 kg (15.4 lbs) over 40 weeks. Nausea is most common in the first week or two after this step-up, then tends to fade.

Some patients achieve adequate glycemic control at 5 mg and stay here long-term. There is no requirement to keep increasing the dose if your treatment goals are being met.

7.5 mg

An intermediate step that was not used in all clinical trials. Some prescribers use it as a bridge for patients who had difficulty tolerating the jump from 5 mg to 10 mg. The 7.5 mg dose provides incremental improvement in A1C and weight reduction.

10 mg

In SURPASS-2, the 10 mg dose reduced A1C by 2.37 percent and body weight by 9.6 kg (21.2 lbs) over 40 weeks. The side effect profile is similar to lower doses, though gastrointestinal symptoms may temporarily reappear for some patients after the dose increase.

15 mg

The maximum approved dose. In SURPASS-2, the 15 mg dose achieved a 2.46 percent A1C reduction and 12.4 kg (27.3 lbs) of weight loss over 40 weeks compared to semaglutide 1 mg. The SURMOUNT-1 trial, which studied tirzepatide specifically for obesity, showed an average 22.5 percent body weight reduction at this dose over 72 weeks.

Not every patient needs the 15 mg dose, and not everyone tolerates it. The decision to titrate to maximum should be based on whether the clinical benefit justifies any additional side effects.

Handling Missed Doses

The Mounjaro prescribing information provides clear guidance on missed doses:

• If fewer than 4 days (96 hours) have passed since the missed dose was due, take it as soon as possible and resume your regular schedule.
• If 4 or more days have passed, skip the missed dose entirely and take the next dose on your regular day.

Do not double up on doses. If you miss multiple weeks, contact your prescriber. They may recommend restarting at a lower dose to reduce the risk of gastrointestinal side effects.

Practical Injection Tips

Mounjaro comes in a single-dose pen that does not require mixing or dose dialing. Each pen contains one pre-set dose. A few tips that patients commonly find helpful:

• Let the pen reach room temperature for 30 minutes before injecting. Cold injections tend to sting more.
• Rotate injection sites. Alternate between your abdomen (at least 2 inches from the navel), front of thighs, and back of upper arms. This helps prevent lipohypertrophy, a buildup of fat tissue that can interfere with absorption.
• Inject on the same day each week. You can change the day if needed, as long as at least 3 days (72 hours) have passed since your last injection.
• Hold the pen in place for 10 seconds after the click, even though the label says 6 seconds is sufficient. This gives the medication more time to disperse under the skin and may reduce injection site reactions.
• Do not rub the injection site. Light pressure with a cotton ball is fine if there is minor bleeding.

When Titration Gets Extended

In practice, many patients take longer than the minimum 20 weeks to reach their final dose. This is normal and often appropriate. Reasons a prescriber might delay titration include:

• Persistent nausea or vomiting at the current dose
• Significant gastrointestinal symptoms that affect quality of life or nutrition
• Adequate glycemic control already achieved at a lower dose
• Concerns about dehydration, particularly in older patients or those with kidney disease

There is no clinical penalty for staying at a lower dose longer. The SURPASS trials used minimum 4-week intervals, but real-world practice often allows 6 to 8 weeks at each step. The goal is to find the lowest effective dose that you tolerate well.

Dose and Supply Considerations

Each Mounjaro pen is single-use. At all five dose levels, the pen is packaged in cartons of 4 pens (a one-month supply). When your prescriber writes a new prescription for a higher dose, you will receive a new carton with pens at that dose level.

If you have leftover pens at your current dose after titrating up, do not use them to supplement the higher dose. Each pen delivers a fixed, single dose. Store unused pens in the refrigerator and consult your pharmacy about disposal.